Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,957 total articles
Toll Brothers, Inc., a leading luxury home builder listed on NYSE as TOL, announced the final home available for purchase at its CrossCreek community in Cumming, Georgia. Priced at $1.372 million, the last opportunity offers a spacious five-bedroom residence in a highly sought-after location with top schools and amenities. This marks the closing ph…
Li Auto Inc. announced a put right notification for holders of its 0.25% Convertible Senior Notes due 2028, allowing holders to require the company to repurchase their notes at 100% principal plus accrued interest on May 1, 2026. The exercise period runs until April 29, 2026, and if all notes are tendered, Li Auto will repurchase approximately $862…
Terra Property Trust, Inc. disclosed the results of its exchange offers to swap existing unsecured senior notes due in 2026 for new secured senior notes due in 2029. While substantial tendering of existing notes occurred, the company did not receive sufficient consents to amend the indenture governing its 6.00% senior notes, so the proposed amendme…
Hudbay Minerals Inc. announced its annual mineral reserve and resource update, highlighting mine life extensions across its operations and a significantly improved three-year production forecast. The company affirmed its 2026 production guidance and issued new guidance for 2027 and 2028, projecting a 24%-28% increase in consolidated copper producti…
PMGC Holdings Inc.'s subsidiary NorthStrive Biosciences announced a third amendment to its license agreement with Korean biotech MOA Life Plus updating timelines and development milestones for dual myostatin inhibitor assets EL-32 and EL-22, focusing on muscle preservation during weight loss treatment. The amendment reflects aligned R&D and regulat…
BioXcel Therapeutics has submitted a supplemental New Drug Application (sNDA) with the FDA seeking approval for IGALMI in an at-home setting to treat acute agitation associated with bipolar disorders and schizophrenia. The timeline suggests potential approval as early as year-end 2026. The company is advancing commercial launch plans based on a rec…
Vera Therapeutics announced inducement compensation to Jane Wright-Mitchell, its newly appointed Chief Legal Officer, consisting of stock options and restricted stock units in accordance with Nasdaq rules. These awards are part of the company’s 2024 Inducement Plan and vest over four years to encourage retention and align interests with shareholder…
KANZHUN LIMITED, trading as BOSS Zhipin on Nasdaq (BZ) and HKEX (2076), announced it repurchased 506,252 shares worth approximately RMB23.6 million on March 26, 2026. Year-to-date, the company has spent more than RMB500 million on share repurchases, signaling strong commitment to enhancing shareholder returns.
Cue Biopharma announced a CEO transition with Lucinda Warren stepping in as interim president and CEO following Usman Azam's departure. Warren brings over 30 years of pharmaceutical and biotech experience and has been instrumental in securing key deals for the company. The firm plans to advance its lead autoimmune therapy, CUE-401, into clinical tr…
Presurance Holdings reported its financial results for Q4 and full year 2025, showing a deliberate exit from commercial lines with zero premium from that segment in Q4 and a 12.7% increase in personal lines production. The company continues to face significant adverse developments from prior commercial lines business, resulting in large net losses …
Editas Medicine announced that the U.S. Patent and Trademark Office has reaffirmed the Patent Trial and Appeal Board's prior decision recognizing the Broad Institute as the first inventor of CRISPR/Cas9 gene editing technology in human cells. This ruling secures critical intellectual property rights exclusively licensed to Editas for developing and…
ADMA Biologics issued a statement refuting allegations made by short seller Culper Research concerning competitive positioning, inventory management, and accounting practices. The company emphasized steady growth in demand and utilization of its ASCENIV immune globulin product over the past two years, inventory levels aligned with industry standard…
Instil Bio, Inc. disclosed its financial results for Q4 and full-year 2025, reporting a net loss but maintaining a strong cash position of $76.3 million expected to fund operations beyond 2027. The company discontinued clinical development of AXN-2510 via its subsidiary Axion Bio and is now focusing on strategic growth through potential acquisition…
BiomX Inc. received a notice from NYSE American indicating non-compliance with continued listing standards due to insufficient stockholders' equity amid repeated losses. The company must submit a plan to regain compliance by September 2027 or face potential delisting. Additionally, an audit included a going concern qualification, raising financial …
Sotherly Hotels Inc. announced its Board of Directors' decision to voluntarily delist its Preferred Stock from Nasdaq and transition the shares to the OTC Market following a recent merger. Despite the change, Sotherly will maintain its status as a real estate investment trust and continue SEC reporting. The move follows a merger where the majority …
Calidi Biotherapeutics announced key operational milestones including partnering with Avance Clinical to accelerate CLD-401 clinical trial initiation in Australia and Matica Bio for GMP manufacturing. The company received supportive feedback from the FDA on its IND filing plans for CLD-401 expected by end of 2026, presented promising data on in sit…
Aqua Metals, a pioneer in battery metals recycling using AquaRefining technology, will announce its financial results for Q4 and full-year 2025 on March 31, 2026, along with a business update and an investor conference call.
Auddia Inc. will execute a 1-for-7.7 reverse stock split effective April 1, 2026, aiming to increase its stock price above the $1.00 minimum bid price requirement of Nasdaq and maintain its listing. The reverse split will adjust outstanding shares, preferred stock, warrants, stock options, and restricted stock units proportionally without changing …
Crescent Biopharma announced the grant of stock options to three new non-executive employees as inducement awards to facilitate their employment. The options total 35,325 shares with a 10-year term and an exercise price set at the closing market price of $13.50 per share. Vesting occurs over four years, incentivizing employee retention. Crescent is…
Precision Optics Corporation, a leading medical and defense/aerospace optical instruments manufacturer, announced the pricing of an upsized $10 million public offering of 2,777,777 shares at $3.60 per share. The oversubscribed offering attracted institutional investors and participation by company executives. Proceeds will be used for working capit…
Super League Enterprise, Inc. reported its fourth quarter and full year 2025 financial results, highlighting its strongest revenue quarter of the year, improved pro forma EBITDA by 31% year-over-year, and a debt-free balance sheet with $14 million cash. The company has diversified revenue streams, reduced operating costs, expanded gross margin to 4…
LM Funding America, Inc. reported Q4 2025 revenue of $2.4 million, up 8.7% sequentially and 19.2% year-over-year due to higher Bitcoin mining output, producing 22.0 Bitcoin. Despite increased production and expanded operations, the company posted a net loss of $17.9 million, driven by lower Bitcoin prices, impairment on mining equipment, and increa…
Total Return Securities Fund (NYSE: SWZ) has announced that its 2026 Annual Meeting of Stockholders will be held on June 11, 2026, at its Bulldog Investors LLP office. Stockholder proposals and director nominations must be submitted by April 17, 2026, to be considered for the meeting.
Diginex Limited plans an Extraordinary General Meeting to approve an 8-for-1 share consolidation and increase authorized share capital. This move aims to comply with Nasdaq's minimum bid price requirement after receiving a compliance warning due to share price falling below $1. The changes are not expected to materially affect market capitalization…
NIP Group Inc. announced receipt of a Nasdaq Deficiency Letter due to its American Depositary Shares trading below the $1.00 minimum bid price requirement for over 30 consecutive business days. The company has 180 days to regain compliance or potentially face delisting. The notice has no immediate effect on trading, and the company intends to take …
